HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

Singapore: Temasek takes stake in HMI

SGX-listed private healthcare provider Health Management International has announced S$11 million (US$8.1 million) investment from Temasek subsidiary Heliconia Capital Management.

HMI will issue 16.9 million new ordinary shares at S$0.65 per share to Orchid 2 Investments which is managed and controlled by Heliconia. This investment means that Heliconia will hold a 2% stake in the enlarged share capital of the group.

“Heliconia has strong interest in the healthcare sector as it ties in well with regional trends of growing middle class and ageing population. We hope to work closely with HMI to explore more opportunities where we can collaborate,” said Heliconia CEO Derek Lau.

At the same time as the investment HMI announced stellar results for the first quarter of the year. Profits more than doubled to S$13.8 million on revenues that rose 6.9% to S$117.1 million.  

Profits jumped this quarter in the wake of the wake of the consolidation exercise completed at the end of March. As well as strong operational performance, 100% of net income is now attributable to HMI shareholders.

The group registered growth from both foreign and local patients as total patient load increased 5.4%. In addition, average outpatient bill sizes increased 12.2%, while average inpatient bill sizes increased 3.6%. This was mainly attributed to higher revenue intensity and increasingly complex surgeries. During the quarter, the group’s operational bed occupancy remained stable at 61.3%.

In light of the rising demand for healthcare across the region, the group has embarked on expansion initiatives to capture growth opportunities. HMI’s Mahkota hospital plans to increase operational bed capacity from 266 beds to 300 beds during the financial year, while at Regency construction on a new hospital extension block will begin this year.

The new block will more than double existing capacity with additional inpatient beds, clinical services, operating theatres and clinical suites for sale or rental to doctors. The US38 million expected construction cost will be funded by debt and internal cash resources.

When it completes in 2021, Regency will become a 380-bed tertiary hospital, with potential to expand capacity to 500 beds. In the near term, Regency is increasing its operational bed capacity from 166 beds to 200 beds.

“To capture opportunities within medical tourism, we continue to leverage on our 16 patient referral offices across Indonesia, Malaysia and Singapore. We have also taken the initiative to broaden patient referrals to Regency and Mahkota through joint overseas marketing initiatives. Looking ahead, we remain well poised to grow our market share and attract more foreign patients to our hospitals,” said CEO Chin Wei Jia.

Posted on: 14/11/2017 UTC+08:00


Paragon Care, a leading distributor and manufacturer supplying medical equipment to hospitals, is to raise A$69.8 million (US$54.6 million) in a fully underwritten offer on the ASX.
Parkway Life REIT, which is owned by IHH Healthcare, is to acquire Konosu Nursing Home Kyoseien, a nursing rehabilitation facility in Greater Tokyo, under a sale-and-leaseback agreement with Iryouhoujin Shadan Kouaikai for ¥1.5 billion (US$13.7 million).
New Zealand-based cancer diagnostics company Pacific Edge (PEB) has entered into an agreement with MediNcrease Health Plans, a US national provider network, to make its bladder cancer diagnostic test available.
Beijing-based paediatric centre Dr Cuiyutao Healthcare has raised Series C plus funding led by New Oriental Education & Technology Group. The size of the funding has not been disclosed, but is understood to be in the millions of US dollars.
Kelantan-based Ain Medicare, which manufactures both blood and renal medical devices as well as pharmaceutical products, has raised M$20 million (US$5.1 million) in a strategic investment from Malaysian government investment company A-BIO.
Anthea Muir has been named chief executive of Australian cosmetic clinic chain Laser Clinics Australia with Paul McClintock as chairman. Muir comes from Luxottica Group while McClintock is best known as the former chairman of Medibank Private.
Harmonicare Medical, the largest private obstetrics and gynaecology specialty hospital group in China, has increased its loan to help the Rmb160 million (US$25.3 million) construction of Wuxi Harmonicare, a new obstetrics and gynaecology hospital in Wuxi, Jiangsu Province.
Higher sales have given a boost to third quarter results at medical rubber glove manufacturer Hartalega Holdings.


A new paper from KPMG looks at the disconnect between consumer expectations and the current healthcare experience of patients in Australia.
Gan Kim Yong, Singapore’s minister for health, explains why integrated care is important in the context of an ageing population.
Not having featured before 2015, Chinese investment in Australia’s healthcare sector has surged over the past three years. It has reached A$5.5 billion (US$4.5 billion) across 16 completed deals, according to a new report from KPMG and The University of Sydney Business School.
Michael Griffiths, regional director of healthcare at specialist insurance brokers Howden, explains how insurance is an answer to the region’s healthcare crisis.
Nomaan Mirza, principal equity specialist at the International Finance Corporation, looks at healthcare equity opportunities in emerging markets.
The healthcare industry in Asia-Pacific is expected to grow at 11.1% in 2018, representing one of the fastest growing regions in the world, as the global healthcare economy averages a 4.8% annual growth rate.
Technologist, business leader, and philanthropist Bill Gates explains why global health needs the private sector.
Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon from international management consultants Arthur D. Little explain how medical technology companies can manage going digital.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices